Cleared Traditional

K152740 - Radifocus Glidewire

K152740 is an FDA 510(k) clearance for Radifocus Glidewire, manufactured by Ashitaka Factory of Terumo Corp.. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 54-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
54d
Days
Class 2
Risk

K152740 is an FDA 510(k) clearance for the Radifocus Glidewire. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Ashitaka Factory of Terumo Corp. (Fujinomiya Shizuoka, JP). The FDA issued a Cleared decision on November 16, 2015 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K152740

510(k) Number K152740 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2015
Decision Date November 16, 2015
Days to Decision 54 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 125d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Terumo Medical Corporation
PHEBE VARGHESE

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQX Wire, Guide, Catheter

All 740
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K152740.
PW Guidewires
K152497 · Tatara Vascular, LLC · Jan 2016
Fighter Guidewire, Marvel Guidewire, Samurai Guidewire, Samurai RC Guidewire, Stretch Extension Wire
K151840 · Boston Scientific Corporation · Dec 2015
R350 guidewire
K151234 · Vascular Solutions, Inc. · Nov 2015
HI-TORQUE BALANCE
K152709 · Abbott Vascular · Oct 2015
Hi-Torque Command 18 Guide Wire
K152404 · Abbott Vascular · Sep 2015
Medtronic Confida Brecker Guidewire
K150465 · Medtronic Core Valve, LLC · Aug 2015